ArticleCancer management and research2018
Can contemporary trials of chemotherapy for HER2-negative metastatic breast cancer detect overall survival benefit?
Sherko Kümmel et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papertrialcites it